Regional Anesthesia
DrugTransverse abdominal Plane(TAP) Block with long acting Exparel placed by a regional anesthesiologist.
NCT Number: NCT06617949
The purpose of this study is to investigate the efficacy of three different modalities of post-operative pain control in parturient with opioid use disorders. The investigators aim to determine whether the different approach utilized show better outcomes with pain management and if there are any association with reduction of symptoms of anxiety, depression, and overall well-being.
Interested in participating?
Request Info18 year–40 year
Female
Interventional
Early Phase 1
Froedtert Hospital, Milwaukee, Wisconsin, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transverse abdominal Plane(TAP) Block with long acting Exparel placed by a regional anesthesiologist.
This group will be administered epidural PCA as a modality for pain control post cesarian section
Epidural group will receive pain control via a local anesthetic intermediate bolus infusion
Time frame: immediately after the study intervention and up to post op day 2
Number of participants with significant change in pain assessment scores and any association with reduction of symptoms of anxiety, depression, and overall well-being.
Contact information is provided by the study sponsor or research team.
Christopher Fadumiye, MD
CONTACT
Meredith Albrecht, MD, PhD
CONTACT
Medical College of Wisconsin
Other
Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications: Efficacy and Safety Outcomes.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07278427
Chemically-Induced Disorders, Child Maltreatment
Columbus, Ohio, United States
View Trial DetailsNCT06880705
Acquired Immunodeficiency Syndrome, Behavior
Chicago, Illinois, United States
View Trial DetailsNCT07197476
Acute Stress Disorder, Chemically-Induced Disorders
Providence, Rhode Island, United States
View Trial DetailsNCT07215221
Brain Diseases, Brain Injuries
Columbus, Ohio, United States
View Trial Details